LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.41 | 84.90 | 2928 | 8766 | 0.3340 | 0.6976 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.11 | 84.90 | 2552 | 8988 | 0.2839 | 0.6586 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.11 | 84.90 | 2584 | 8988 | 0.2875 | 0.6617 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.11 | 84.90 | 2888 | 8988 | 0.3213 | 0.6894 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.11 | 84.90 | 2958 | 8988 | 0.3291 | 0.6954 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.81 | 84.90 | 2590 | 9132 | 0.2836 | 0.6594 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.81 | 84.90 | 2621 | 9132 | 0.2870 | 0.6623 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.81 | 84.90 | 3043 | 9132 | 0.3332 | 0.6995 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.81 | 84.90 | 3114 | 9132 | 0.3410 | 0.7053 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.52 | 84.90 | 2680 | 9214 | 0.2909 | 0.6662 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.52 | 84.90 | 2715 | 9214 | 0.2947 | 0.6694 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.52 | 84.90 | 3129 | 9214 | 0.3396 | 0.7048 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.52 | 84.90 | 3190 | 9214 | 0.3462 | 0.7096 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.22 | 84.90 | 2756 | 9343 | 0.2950 | 0.6705 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.22 | 84.90 | 2793 | 9343 | 0.2989 | 0.6738 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.22 | 84.90 | 3058 | 9343 | 0.3273 | 0.6963 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.22 | 84.90 | 3121 | 9343 | 0.3340 | 0.7014 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 75.93 | 84.90 | 2870 | 8970 | 0.3199 | 0.6882 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 75.93 | 84.90 | 2901 | 8970 | 0.3234 | 0.6909 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 75.93 | 84.90 | 3334 | 8970 | 0.3717 | 0.7262 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 75.93 | 84.90 | 3395 | 8970 | 0.3785 | 0.7309 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 77.64 | 84.90 | 2967 | 9245 | 0.3209 | 0.6908 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 77.64 | 84.90 | 2996 | 9245 | 0.3240 | 0.6932 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 77.64 | 84.90 | 3537 | 9245 | 0.3826 | 0.7353 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 77.64 | 84.90 | 3585 | 9245 | 0.3878 | 0.7387 | MN20160318_Q02 | F12 |